HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jens Schittenhelm Selected Research

somatostatin receptor 2

8/2022The immunohistochemical expression of SSTR2A is an independent prognostic factor in meningioma.
8/2022Correction to: The immunohistochemical expression of SSTR2A is an independent prognostic factor in meningioma.
2/2022Differences in the expression of SSTR1-5 in meningiomas and its therapeutic potential.
1/2018High Expression of Somatostatin Receptors 2A, 3, and 5 in Corticotroph Pituitary Adenoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jens Schittenhelm Research Topics

Disease

65Neoplasms (Cancer)
11/2022 - 07/2006
24Glioma (Gliomas)
02/2022 - 12/2009
15Astrocytoma (Pilocytic Astrocytoma)
04/2022 - 02/2008
14Meningioma (Meningiomas)
08/2022 - 05/2009
14Glioblastoma (Glioblastoma Multiforme)
01/2022 - 02/2008
13Brain Neoplasms (Brain Tumor)
04/2022 - 01/2010
6Neurilemmoma (Schwannoma)
01/2021 - 01/2010
5Neuroepithelial Neoplasms (Gliomatosis Cerebri)
04/2022 - 08/2007
5Oligodendroglioma
12/2020 - 02/2011
5Intellectual Disability (Idiocy)
09/2019 - 01/2016
4Ependymoma
11/2022 - 08/2012
4Neurofibromatosis 2 (Neurofibromatosis Type II)
08/2022 - 11/2019
4alpha-Thalassemia
09/2019 - 01/2017
4Neurofibrosarcoma (MPNST)
07/2017 - 01/2010
4Hypoxia (Hypoxemia)
01/2017 - 04/2011
3Medulloblastoma
01/2021 - 08/2012
3Nerve Sheath Neoplasms (Nerve Sheath Neoplasm)
01/2020 - 01/2010
3Melanoma (Melanoma, Malignant)
06/2019 - 01/2013
3Reperfusion Injury
01/2017 - 04/2009
3Primitive Neuroectodermal Tumors (PNET)
02/2016 - 08/2012
3Ganglioglioma
01/2016 - 10/2007
3Choroid Plexus Neoplasms (Choroid Plexus Tumor)
10/2011 - 07/2006
3Ischemia
04/2010 - 06/2008
2B-Cell Lymphoma (Lymphoma, B Cell)
10/2021 - 11/2016
2Acoustic Neuroma (Acoustic Neurinoma)
01/2021 - 11/2019
2Central Nervous System Neoplasms
06/2019 - 10/2007
2Pituitary Neoplasms (Pituitary Adenoma)
01/2018 - 12/2014
2Sarcoma (Soft Tissue Sarcoma)
01/2016 - 04/2014
2Solitary Fibrous Tumors
04/2014 - 05/2013
2Carcinoma (Carcinomatosis)
01/2013 - 07/2006
2Neoplasm Metastasis (Metastasis)
01/2013 - 06/2011
2Inflammation (Inflammations)
08/2011 - 04/2009
2Gliosis
02/2010 - 07/2008
1Neuroendocrine Tumors (Neuroendocrine Tumor)
04/2022
1Necrosis
02/2022
1Disease Progression
01/2022
1Uveitis
01/2022
1Encephalitis (Encephalitis, Rasmussen)
10/2021
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
06/2021
1Second Primary Neoplasms (Neoplasms, Second)
01/2021
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2021
1Residual Neoplasm
01/2021

Drug/Important Bio-Agent (IBA)

15Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
04/2021 - 02/2011
12Proteins (Proteins, Gene)FDA Link
11/2022 - 02/2008
11DNA (Deoxyribonucleic Acid)IBA
11/2021 - 05/2009
6ParaffinIBA
07/2022 - 07/2008
6AntibodiesIBA
05/2021 - 01/2010
6Biological ProductsIBA
01/2021 - 06/2013
5Histones (Histone)IBA
01/2021 - 12/2013
5MethyltransferasesIBA
09/2019 - 08/2012
5IntegrinsIBA
10/2016 - 01/2013
4somatostatin receptor 2IBA
08/2022 - 01/2018
4Somatostatin Receptors (Somatostatin Receptor)IBA
08/2022 - 01/2018
4Biomarkers (Surrogate Marker)IBA
12/2021 - 01/2010
3somatostatin receptor type 1IBA
08/2022 - 01/2018
3Phosphotransferases (Kinase)IBA
04/2022 - 10/2013
3Glucose (Dextrose)FDA LinkGeneric
02/2022 - 07/2012
3O-(6)-methylguanineIBA
09/2019 - 01/2017
35'-Nucleotidase (5' Nucleotidase)IBA
01/2017 - 11/2008
3Purinergic P1 Receptors (Adenosine Receptor)IBA
01/2017 - 04/2009
2Radioisotopes (Radionuclides)IBA
04/2022 - 02/2022
22,6-dinitrotoluene (DNT)IBA
04/2022 - 08/2007
2GadoliniumIBA
02/2022 - 09/2018
2Messenger RNA (mRNA)IBA
01/2022 - 10/2013
2CytokinesIBA
10/2021 - 12/2019
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
03/2021 - 11/2019
2Lysine (L-Lysine)FDA Link
01/2021 - 12/2013
2RNA (Ribonucleic Acid)IBA
01/2020 - 05/2009
2Angiopoietin-2IBA
12/2019 - 01/2016
2Codon (Codons)IBA
12/2018 - 06/2016
2Formaldehyde (Formol)FDA Link
07/2017 - 03/2013
2Anticonvulsants (Antiepileptic Drugs)IBA
01/2017 - 12/2015
2Neurofibromin 1 (Neurofibromin)IBA
01/2016 - 04/2014
2Transcription Factors (Transcription Factor)IBA
07/2014 - 04/2014
2SynaptophysinIBA
06/2013 - 01/2009
2EnzymesIBA
07/2012 - 05/2009
2Adenosine (Adenocard)FDA LinkGeneric
04/2011 - 11/2008
22- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
06/2009 - 07/2006
1PAX6 Transcription FactorIBA
11/2022
1Peptide Receptors (Peptide Receptor)IBA
04/2022
1Peptides (Polypeptides)IBA
04/2022
1Monophenol Monooxygenase (Tyrosinase)IBA
04/2022
1Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA
04/2022
1Amino AcidsFDA Link
01/2022
1NestinIBA
01/2022
1axicabtagene ciloleucelIBA
10/2021

Therapy/Procedure

15Therapeutics
04/2022 - 08/2010
10Radiotherapy
02/2022 - 10/2007
4Adjuvant Radiotherapy
08/2022 - 11/2019
3Drug Therapy (Chemotherapy)
01/2020 - 02/2008
2Hematopoietic Stem Cell Transplantation
06/2021 - 11/2016
2Immunotherapy
07/2014 - 01/2010
1Craniotomy
03/2022
1Osteotomy
03/2022
1Vitrectomy
01/2022
1Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
06/2021
1Organ Transplantation
06/2021
1Investigational Therapies (Experimental Therapy)
01/2021
1Cranial Irradiation
01/2021
1Aftercare (After-Treatment)
01/2021